As of 2025-06-20, the Relative Valuation of Rigel Pharmaceuticals Inc (RIGL) is 22.46 USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.36 USD, the upside of Rigel Pharmaceuticals Inc based on Relative Valuation is 16.0%.
The range of the Relative Valuation is 16.48 - 37.16 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 17.9x | 12.3x |
| Forward P/E multiples | 17.3x - 24.9x | 20.3x |
| Fair Price | 16.48 - 37.16 | 22.46 |
| Upside | -14.9% - 91.9% | 16.0% |
| Date | P/E |
| 2025-06-17 | 9.21 |
| 2025-06-16 | 9.82 |
| 2025-06-13 | 9.86 |
| 2025-06-12 | 10.24 |
| 2025-06-11 | 10.19 |
| 2025-06-10 | 10.36 |
| 2025-06-09 | 10.50 |
| 2025-06-06 | 10.33 |
| 2025-06-05 | 10.08 |
| 2025-06-04 | 9.87 |
| 2025-06-03 | 9.80 |
| 2025-06-02 | 9.69 |
| 2025-05-30 | 9.23 |
| 2025-05-29 | 9.39 |
| 2025-05-28 | 9.22 |
| 2025-05-27 | 9.43 |
| 2025-05-23 | 9.11 |
| 2025-05-22 | 9.48 |
| 2025-05-21 | 10.07 |
| 2025-05-20 | 9.67 |
| 2025-05-19 | 9.47 |
| 2025-05-16 | 9.53 |
| 2025-05-15 | 9.49 |
| 2025-05-14 | 8.79 |
| 2025-05-13 | 8.79 |
| 2025-05-12 | 8.95 |
| 2025-05-09 | 9.02 |
| 2025-05-08 | 9.08 |
| 2025-05-07 | 8.88 |
| 2025-05-06 | 8.78 |
| 2025-05-05 | 9.19 |
| 2025-05-02 | 9.31 |
| 2025-05-01 | 9.00 |
| 2025-04-30 | 9.40 |
| 2025-04-29 | 9.41 |
| 2025-04-28 | 9.33 |
| 2025-04-25 | 9.27 |
| 2025-04-24 | 9.16 |
| 2025-04-23 | 8.73 |
| 2025-04-22 | 8.53 |
| 2025-04-21 | 8.14 |
| 2025-04-17 | 8.10 |
| 2025-04-16 | 7.93 |
| 2025-04-15 | 8.19 |
| 2025-04-14 | 8.27 |
| 2025-04-11 | 8.02 |
| 2025-04-10 | 7.82 |
| 2025-04-09 | 8.30 |
| 2025-04-08 | 7.87 |
| 2025-04-07 | 8.19 |